Skip to content
Kalpvruksh Markets
Offline Log in

TORNTPHARMNSEOffline

TORRENT PHARMA · INE685A01028 · Large Cap · #61
4,710.00−28.50 (−0.60%)last close · 05 Nov 2026
Prev close
4,738.50
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹1,43,630 cr
52-week range · to 05 Nov 20263,553.45,122.8

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

TORNTPHARM is 8% below its 52-week high, above its 200-day average, behind Healthcare by 6.7 pts over 3 months — a Large Cap company, #61 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 8% below its 52-week high
  • behind its industry by 6.7 pts over 3 months · rank 38 of 44 in Healthcare · −3.7% vs Nifty 500
  • traded value 1.3× usual · delivery 64% vs 62% usual
  • short build-up today · IV 21%, 34th pct of its year · expected move ±4.7% to expiry
  • FPI +1.8 pp · DII +3.6 pp · MF schemes in Sept 2026: 125 bought, 68 cut · no promoter pledge · quarter ended 2026-09-30
  • Sept 2026 quarter: profit −10% year on year · revenue +51%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹1,43,630 cr
Rank
#61
Cap band
Large Cap
Nearest cut-off — Large / Mid
+34.97% from ₹1,06,417 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.5×
median 2,42,018
Delivered
3,55,341
Of volume
69%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+2.8%−2.8 pts—
1 month−1.3%−5.6 pts−5.0 pts
3 months−5.8%−3.7 pts−6.7 pts
6 months+8.1%+7.6 pts−2.5 pts
1 year+30.7%+34.2 pts—

Industry: Healthcare (Nifty 500 classification) · rank 38 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+2.2%
above
vs 50-day average
−1.6%
below
vs 200-day average
+4.1%
above
ATR (14)
2.5%
typical daily range
Volatility
18%
1 month, annualised
Beta
0.37
vs Nifty 500, 1 year
Traded value
1.3×
vs usual
Delivery
64%
usual 62%
From the 52-week high
−8.1%
place in range 74% (0 = at the low)

F&O

Where option open interest clusters

expiry 23 Nov 2026 · 18 days

Spot
4,710.01
Max pain
4,600
−2.3% from spot
Largest call OI (strike)
Largest put OI (strike)

Near expiry. Max pain is the strike at which option buyers’ total payout would be least; strikes with the most open interest are where positions cluster.

Volatility & expected move

ATM IV
21.2%
near expiry
IV 30
21.2%
IV rank
26
0–100 within its year
IV percentile
34
days in the year below today
Expected move to expiry
±221.5
±4.7% · one standard deviation
Range
4,489 – 4,932
Rollover
5%
futures OI in next expiries

Futures build-up, by day

all expiries' OI · today: short build-up

SessionBuild-upFuture priceOI, all expiries
05 Nov 2026short build-up−0.0%+0.5%
04 Nov 2026long build-up+1.9%+0.0%
03 Nov 2026short covering+1.1%−1.1%
02 Nov 2026short build-up−1.2%+0.1%
30 Oct 2026long build-up+1.1%+2.4%
29 Oct 2026short covering+0.1%−0.7%
28 Oct 2026short build-up−0.3%+0.6%
27 Oct 2026long build-up+1.2%+2.3%
26 Oct 2026long build-up+0.8%+5.8%
23 Oct 2026short build-up−2.5%+2.7%

From the exchanges’ F&O bhavcopies. A description of positions, not a forecast. Open interest across the market.

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters68.3%68.3%68.3%60.8% −7.5
FPI16.1%16.2% +0.115.4% −0.717.2% +1.8
Mutual funds4.8%4.5% −0.44.9% +0.58.8% +3.9
Other DII4.2%4.5% +0.34.8% +0.34.6% −0.2
Individuals4.0%4.1% +0.15.0% +0.96.9% +1.9
Others2.5%2.4%1.5% −1.01.7% +0.2

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
1,42,140
Individuals
1,32,916

Indian passive funds’ stake

2026-06-30

Of free float
3.58%
Of all shares
1.14%
Schemes
135
Days to unwind
9.5
at 100% of volume

38,44,219 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
281
135 index · 146 active
Bought more
142
Sold some
57
5 closing out
FundSharesChangeDid
Edelweiss Arbitrage Fund-Reg(G)Active+91,125+743.9%bought
Aditya Birla SL Arbitrage Fund(G)Active+95,875+435.8%bought
Edelweiss Flexi Cap Fund-Reg(G)Active+61,919+392.3%bought
WOC Flexi Cap Fund-Reg(G)Active−75,875−100.0%closing out
WOC Large Cap Fund-Reg(G)Active−57,822−98.9%closing out
Nippon India Arbitrage Fund(G)Active−18,750−98.7%closing out

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2632019106617+3.1%₹13,293 cr
Aug 2630833976414+4.5%₹13,613 cr
Jul 26288691334014+68.4%₹13,169 cr
Jun 262333397289+10.0%₹7,053 cr
May 26209875356−0.6%₹6,120 cr
Apr 2620616763219+0.1%₹5,845 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 0 of 5 disclosures

None in the latest 50 disclosures — switch to Everyone.

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Torrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    26 Oct 2026
  • Credit rating
    Torrent Pharmaceuticals Limited has informed the Exchange about Credit Rating
    08 Oct 2026
  • Scheme / acquisition
    Torrent Pharmaceuticals Limited has informed the Exchange about Acquisition - Disclosure pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations )
    28 Sept 2026
  • Board outcome
    Torrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    25 May 2026
  • Board outcome
    Torrent Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2026.
    25 May 2026

TORNTPHARM: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹9Final29 May 202629 May 2026
EarlierDividend₹29Interim18 Feb 202619 Feb 2026
EarlierDividend₹6Final20 Jun 202520 Jun 2025
EarlierDividend₹26Interim31 Jan 202501 Feb 2025
EarlierDividend₹6Final21 Jun 202421 Jun 2024
EarlierDividend₹22Interim12 Feb 202412 Feb 2024
EarlierDividend₹8Final23 Jun 202323 Jun 2023
EarlierDividend₹14Interim03 Feb 202303 Feb 2023
EarlierBonus1:1—08 Jul 202211 Jul 2022
EarlierDividend₹8Final03 Jun 202206 Jun 2022

14 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.